-
Mashup Score: 6
DURHAM, N.C. – The world’s first partial heart transplant has achieved what researchers have spent more than a year hoping for — functioning valves and arteries that grow along with the young patient, as hypothesized by the pioneering team behind the procedure at Duke Health.
Source: corporate.dukehealth.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 6
DURHAM, N.C. – The world’s first partial heart transplant has achieved what researchers have spent more than a year hoping for — functioning valves and arteries that grow along with the young patient, as hypothesized by the pioneering team behind the procedure at Duke Health.
Source: corporate.dukehealth.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 31
DURHAM, N.C. – Nanoplastics interact with a particular protein that is naturally found in the brain, creating changes linked to Parkinson’s disease and some types of dementia. In a Duke-led study appearing Nov. 17 in Science Advances, the researchers report that the findings create a foundation for a new area of investigation, fueled by the timely impact of environmental factors on human biology.
Source: corporate.dukehealth.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
DURHAM, N.C. – Up to 40% of older surgery patients develop postoperative delirium, a syndrome of confusion that typically occurs in the first few days after surgery. Postoperative delirium is associated with longer hospitalizations, significant distress, and major postoperative complications, but its underlying causes have been elusive.
Source: corporate.dukehealth.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2
DURHAM, N.C. – A man-made antibody successfully prevented organ rejection when tested in primates that had undergone a kidney transplant, Duke Health researchers report. The finding clears the way for the new monoclonal antibody to move forward in human clinical trials. Results of the study appear online Aug. 30 in the journal Science Translational Medicine.
Source: corporate.dukehealth.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2
DURHAM, N.C. – A man-made antibody successfully prevented organ rejection when tested in primates that had undergone a kidney transplant, Duke Health researchers report. The finding clears the way for the new monoclonal antibody to move forward in human clinical trials. Results of the study appear online Aug. 30 in the journal Science Translational Medicine.
Source: corporate.dukehealth.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Results of First Multicenter Trial of Intercessory Prayer, Healing Touch in Heart Patients | Duke Health - 4 year(s) ago
DURHAM, N.C. — Distant prayer and the bedside use of music, imagery and touch (MIT therapy) did not have a significant effect upon the primary clinical outcome observed in patients undergoing certain heart procedures, researchers at Duke Clinical Research Institute (DCRI), Duke University Medical Center, the Durham Veterans Affairs Medical Center (VAMC) and seven other leading academic…
Source: corporate.dukehealth.orgCategories: Cardiologists, Latest HeadlinesTweet
World’s First Partial Heart Transplant Proves Successful in First Year | Duke Health https://t.co/ZahCUDkLQd